BioNTech (BNTX) PT Lowered to $140 at Wells Fargo
Get Alerts BNTX Hot Sheet
Price: $113.12 +21.96%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal lowered the price target on BioNTech (NASDAQ: BNTX) to $140.00 (from $150.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Moderna (MRNA) PT Raised to $89 at Morgan Stanley
- BofA Securities Upgrades Moderna (MRNA) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share